During the past decade, Dayton Gastroenterology, Inc conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 21 clinical trials were completed, i.e. on average, 72.4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 18 clinical trials were completed. i.e. 180% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dayton Gastroenterology, Inc" #1 sponsor was "Takeda" with 5 trials, followed by "Allergan" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Bausch Health Americas, Inc." with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dayton Gastroenterology, Inc" #1 collaborator was "Allergan Sales, LLC" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Dayton Gastroenterology, Inc" are "Crohn's Disease" (6 trials), "Colitis, Ulcerative" (5 trials), "Gastroparesis" (4 trials), "Ulcerative Colitis" (4 trials) and "Diabetes Mellitus" (3 trials). Many other conditions were trialed in "Dayton Gastroenterology, Inc" in a lesser frequency.

Most popular intervention types in "Dayton Gastroenterology, Inc" are "Drug" (35 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Guselkumab Dose 1" (3 trials), "Guselkumab Dose 2" (3 trials), "Guselkumab Dose 3" (3 trials) and "Relamorelin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Dayton Gastroenterology, Inc" are 34 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Dayton Gastroenterology, Inc". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Dayton Gastroenterology, Inc, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Dayton Gastroenterology, Inc, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".